MBOT – microbot medical inc. (US:NASDAQ)

News

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones [Yahoo! Finance]
Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
Microbot Medical (NASDAQ:MBOT) was upgraded by analysts at Roth Capital to a "strong-buy" rating. They now have a $5.50 price target on the stock.
Microbot Medical (NASDAQ:MBOT) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
Microbot Medical (NASDAQ:MBOT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com